Kenneth Howling - Appili Therapeutics Acting Officer
| APLIF Stock | | | USD 0.02 0.0001 0.53% |
Insider
Kenneth Howling is Acting Officer of Appili Therapeutics
| Phone | 902 442 4655 |
| Web | https://www.appilitherapeutics.com |
Appili Therapeutics Management Efficiency
The company has return on total asset
(ROA) of
(0.7049) % which means that it has lost $0.7049 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
(9.3872) %, meaning that it generated substantial loss on money invested by shareholders. Appili Therapeutics' management efficiency ratios could be used to measure how well Appili Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.
Appili Therapeutics has accumulated 4.88
M in total debt with debt to equity ratio
(D/E) of 0.17, which may suggest the company is not taking enough advantage from borrowing. Appili Therapeutics has a current ratio of 1.95, which is within standard range for the sector. Debt can assist Appili Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Appili Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Appili Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Appili to invest in growth at high rates of return. When we think about Appili Therapeutics' use of debt, we should always consider it together with cash and equity.
Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in the infectious disease in Canada. Appili Therapeutics Inc. was incorporated in 2015 and is headquartered in Halifax, Canada. Appili Therapeutics is traded on OTC Exchange in the United States. Appili Therapeutics [APLIF] is a
Pink Sheet which is traded between brokers over the counter.
Management Performance
Appili Therapeutics Management Team
Elected by the shareholders, the Appili Therapeutics' board of directors comprises two types of representatives: Appili Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Appili. The board's role is to monitor Appili Therapeutics' management team and ensure that shareholders' interests are well served. Appili Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Appili Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
Appili Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Appili Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Other Information on Investing in Appili Pink Sheet
Appili Therapeutics financial ratios help investors to determine whether Appili Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Appili with respect to the benefits of owning Appili Therapeutics security.